About Us
History
Fascinated by the road less travelled, the Company has taken its products to different corners of the globe catering predominantly to the “Bottom of the Pyramid” – underserved markets and populations – by offering high–quality, affordable products.
At Caplin, we are our own choice architect, believing that our choice and future is defined by Caplin’s employees. The DNA of our Company is molded and informed by our past, with a laser focus on the future. We sought opportunities in spaces the broad market was not looking at, embraced the unknown and developed an insight into what not to do if we were to succeed.
The Company’s visionary leadership has been conscious to create its own path than getting deterred by roadblocks. Caplin took on the mantle to cater to the healthcare needs of those at the “Bottom of the Pyramid” in the markets the Company operates.
The result of these learnings is that we did not just ensure the survival of our company; we allowed it to flourish. Our past informs our future – and is proof that Caplin will continue to provide the highest quality healthcare products when the patient needs them and at a value that lifts underserved markets.
Who we are
Caplin Steriles USA Inc. is the next contiguous step in our parent company’s storied history of taking the road less travelled to fulfil the healthcare needs of the underserved.
Caplin Steriles USA Inc is the wholly owned subsidiary of Caplin Steriles Ltd India, operating as their sales and marketing arm focused on the U.S. market. Caplin Steriles is an R&D driven company focused on the development and manufacturing of high quality Injectables and Ophthalmic products for Regulated Markets. With an excellent compliance history backed up high levels of automation in its various processes, Caplin Steriles aims to one of the go to suppliers of sterile products for the Regulated Markets.
Both divisions are part of Caplin Point Laboratories Limited, the only mid-sized company in India’s pharmaceutical sector to be engaged in the R&D and manufacture of finished formulations, APIs, and clinical research, with a dominant front-end presence in Latin America. Caplin Point’s manufacturing facilities are approved by the U.S. FDA, EMA, INVIMA and ANVISA.
Caplin Point was established in 1990 by Mr. C.C. Paarthipan, the company’s Chairman, and in 1994 became a publicly traded company in India. Established with the initial purpose of manufacturing ointments, creams and other external applications, the Company has expanded its product portfolio, global market reach and production capabilities.
What we stand for
At Caplin, there is absolutely no compromise on the product quality, innovation, and timely availability of medicines. Over the years, the Company has been aggressively expanding manufacturing, product innovation and R&D capabilities. There has been a consistent and conscious effort to diversify the product mix and expand the Company’s product portfolio. The latest move to digitalize and automate multiple functions of the company would help accelerate the company’s next trajectory of growth.
The four pillars system of growth and strength at Caplin has been the guiding force in ensuring the sustainability and scalability of its operations. These four pillars of Integrity, Quality, Safety and Productivity provide the blueprint to overcome all questions and challenges which the team may encounter.
As a result of this relentless focus and strict adherence to our four pillars, the Company remains debt-free and has cash surplus which strategically positions it to capitalize on opportunities of the future.
